Armie Margaret Lee is a reporter covering private equity. Previously, she was at InvestmentWires, an online media company that focuses on the mutual fund and 401(k) industries. She has also covered real estate and banking for Miami Today and technology for Manila Times in the Philippines.
Recent Articles By The Author
Celgene Shares Rise on Plans to Increase Stock Buybacks
The Summit, N.J.-based biotech firm also plans to enter into an accelerated share repurchase program to buy back $2 billion of stock.
Eli Lilly's Trulicity Benefits From Growth of Diabetes Drugs
Senior vice president Enrique Conterno says the Type-2 diabetes treatment is part of the fast-growing glucagon-like peptide-1 receptor agonists.
Amgen, Novartis Clinch FDA Nod on Migraine Prevention Drug
Aimovig is the first treatment approved by the agency to prevent migraines by blocking the calcitonin gene-related peptide receptor.
Allergan's Meury Talks Market Expansion in Aesthetics
The chief commercial officer's appearance at a Bank of America healthcare conference came a day after Allergan competitor Evolus said it had received a complete response letter regarding its application for Botox rival DWP-450.
Teva Shares Jump After Warren Buffett Doubles Stake in Drugmaker
Berkshire Hathaway hiked its stake in the drugmaker, which is undergoing a restructuring, to 40.5 million shares as of the end of March.
Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing
President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.
FDA Chief Talks Opioid Crisis, Biosimilars
FDA commissioner Scott Gottlieb said at a conference Thursday that the agency has the resources it needs to address the opioid crisis.
Mylan First-Quarter Revenue Misses Estimate Amid Lower Sales of Branded Product
The EpiPen maker saw a 19% drop in North America net sales due in part to lower sales of branded products.
Here's How Medtronic Can Unlock Shareholder Value, Says Analyst
The appointment of Mike Weinstein as senior vice president of strategy has sparked the question of what the med tech firm should do to unlock shareholder value.
Allergan Expects to Finish Strategic Review Quickly, CFO Says
The Dublin-based drugmaker will provide communications on the strategic review in 'weeks, not months,' Allergan CFO Matthew Walsh said at the Deutsche Bank healthcare conference.